Journal
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS
Volume 1147, Issue -, Pages 206-220Publisher
WILEY-BLACKWELL
DOI: 10.1196/annals.1427.037
Keywords
Parkinson's disease; magnetic resonance spectroscopy; mitochondria; neurodegenerative disease; lactate; high-energy phosphates
Ask authors/readers for more resources
Parkinson's disease (PD) is a common and often devastating neurodegenerative disease affecting up to one million individuals in the United. States alone. Multiple lines of evidence support mitochondrial dysfunction as a primary or secondary event in PD pathogenesis; a better understanding, therefore, of how mitochondrial function is altered in vivo in brain tissue in PD is a critical step toward developing potential PD biomarkers. In vivo study of mitochondrial metabolism in human subjects has previously been technically challenging. However, proton and phosphorus magnetic resonance spectroscopy (H-1 and P-31 MRS) are powerful noninvasive techniques that allow evaluation in vivo of lactate, a marker of anaerobic glycolysis, and high energy phosphates, such as adenosine triphosphate and phosphocreatine, directly reflecting mitochondrial function. This article reviews previous H-1 and P-31 MRS studies in PD, which demonstrate metabolic abnormalities consistent with mitochondrial dysfunction, and then presents recent H-1 MRS data revealing abnormally elevated lactate levels in PD subjects.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available